Flexus Biosciences - Ownership and Business Overview

Life ScienceCompany

Flexus Biosciences Ownership

Who owns Flexus Biosciences?

Flexus Biosciences is owned by Bristol-Myers Squibb. It was acquired on February 23, 2015.

Flexus Biosciences Business Overview

Where is Flexus Biosciences headquartered?

Flexus Biosciences is headquartered in San Carlos,, California.

What sector is Flexus Biosciences in?

Flexus Biosciences is a life science company.

When was Flexus Biosciences founded?

Flexus Biosciences was founded in 2013.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Flexus Biosciences, Inc.

75 Shoreway Road Suite D,
San Carlos,, California 94070
United States,
www.flexusbio.com

Flexus is a biotechnology company focused on the discovery, development, and commercialization of small-molecule cancer immunotherapies targeting regulatory T cells. The company is leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression (ARTIS).


 Subscribe to unlock this and 206,651
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.